Hayman Capital Management as of Sept. 30, 2015
Portfolio Holdings for Hayman Capital Management
Hayman Capital Management holds 14 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nmi Hldgs Cl A (NMIH) | 25.9 | $56M | 7.4M | 7.60 | |
| Ypf Sociedad Anonima Spon Adr Cl D Call Option (YPF) | 15.8 | $34M | 2.3M | 15.23 | |
| Impax Laboratories | 9.9 | $21M | 607k | 35.21 | |
| CF Industries Holdings (CF) | 9.6 | $21M | 464k | 44.90 | |
| Gw Pharmaceuticals Ads | 8.9 | $19M | 211k | 91.37 | |
| BioMarin Pharmaceutical (BMRN) | 6.3 | $14M | 130k | 105.32 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $10M | 100k | 104.14 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 4.4 | $9.4M | 265k | 35.59 | |
| Pronai Therapeutics | 4.0 | $8.7M | 422k | 20.52 | |
| Eco-stim Energy Solution | 3.4 | $7.3M | 2.1M | 3.43 | |
| Allergan SHS | 2.2 | $4.8M | 18k | 271.82 | |
| Alcobra SHS | 1.7 | $3.8M | 626k | 6.04 | |
| Endo Intl SHS (ENDPQ) | 1.7 | $3.6M | 53k | 69.29 | |
| Mylan N V Shs Euro | 1.5 | $3.2M | 79k | 40.26 |
